Epidemiology & Risk Factors

  • Most common cause of pediatric hearing impairment.
  • Peak incidence: Ages 6 months to 4 years.
  • Pathophysiology: Fluid accumulation in middle ear cleft without acute systemic/local signs of infection; often follows resolution of Acute Otitis Media (AOM) or arises from Eustachian tube dysfunction (ETD).
  • Risk Factors:
    • Recent episode of AOM (fluid persists in 70% at 2 wks, 40% at 1 mo, 10-25% at 3 mos).
    • Passive smoke exposure.
    • Daycare attendance.
    • Allergic rhinitis / viral URIs.
    • Craniofacial anomalies (e.g., cleft palate, Trisomy 21).
    • Adenoidal hypertrophy.

Clinical Features

  • Key Triad/Pattern: Typically asymptomatic + no signs of acute infection (no fever, no severe otalgia) + hearing loss.
  • History:
    • Parent concern for speech or language delay, inattentiveness, or behavioral issues.
    • Failed routine school or well-child hearing screen.
    • Sensation of ear fullness, clicking, or “popping.”
  • Physical Exam:
    • Afebrile, non-toxic appearance.
    • External auditory canal is normal (no pain with traction of pinna/tragus).

Diagnosis

  • Initial / Physical Exam (Pneumatic Otoscopy):
    • Impaired / decreased TM mobility (essential finding).
    • TM appearance: Amber, dull, or gray; translucent or opaque.
    • No significant bulging (may be neutral or retracted).
    • Air-fluid levels or clear fluid bubbles visible behind the TM.
  • Confirmatory / Objective Testing:
    • Tympanometry: Type B tracing (flat curve indicating decreased TM compliance and middle ear fluid) or Type C (negative pressure).
    • Audiometry (Formal Hearing Test): Demonstrates Conductive Hearing Loss (CHL); indicated if effusion persists ≥ 3 months or if developmental delays are suspected.

Differential Diagnostics

  • Acute Otitis Media (AOM):
    • Diff: Presents with acute signs of inflammation (fever, marked TM bulging, erythema, severe otalgia). OME lacks acute inflammatory signs and significant bulging.
  • Eustachian Tube Dysfunction (ETD without effusion):
    • Diff: TM is retracted with prominent bony landmarks, but lacks air-fluid levels, bubbles, or middle ear fluid on pneumatic otoscopy/tympanometry.
  • Bullous Myringitis:
    • Diff: Presence of painful, fluid-filled vesicles/bullae directly on the outer surface of the TM; severe acute otalgia.
  • Otitis Externa:
    • Diff: Pain elicited with manipulation of the pinna or tragus; canal erythema and edema; TM is typically clear and mobile.
  • Cholesteatoma:
    • Diff: Chronic drainage, white keratinaceous debris or mass in retraction pocket / attic region of TM; progressive bone erosion.

Management

  • First-Line / Initial:
    • Watchful waiting and observation: Re-examine in 3 months.
    • Most cases resolve spontaneously within 3 months. c
    • Do NOT give: Systemic/topical antibiotics, oral/nasal steroids, antihistamines, or decongestants (no clinical benefit in OME).
  • Second-Line / Surgical Intervention:
    • Indications:
      • Bilateral OME persistent for ≥ 3 months with documented hearing loss / speech delay.
      • Recurrent/chronic OME with structural TM damage (e.g., severe retraction, atelectasis).
      • High-risk children (e.g., Down syndrome, cleft palate, sensorineural hearing loss, autism).
    • Procedure of Choice: Tympanostomy tube insertion (myringotomy with ventilation tubes).
    • Adjunctive: Adenoidectomy if concurrent chronic nasal obstruction or recurrent adenoiditis in children ≥ 4 years old.

Complications

  • Conductive Hearing Loss (CHL) (can fluctuate).
  • Delayed speech and language development.
  • TM structural abnormalities:
    • Tympanosclerosis (calcium plaques).
    • Adhesive otitis / TM atelectasis.
    • Retraction pockets predisposing to cholesteatoma formation.